Abstract
We determined the incidence of severe bleeding from gastric antral vascular ectasia (GAVE) after myeloablative hematopoietic cell transplant and the outcomes after treatment with endoscopic neodymium:YAG laser photocoagulation. From 1992 to 2005, the incidence of severe bleeding from GAVE was 6/4491 (0.13%). All patients had received oral busulfan and four had sinusoidal obstruction syndrome. Gastrointestinal bleeding began a median of 53 days after transplant (range 15–2952). After GAVE was diagnosed by endoscopic and histologic findings, a median of three (range 2–7) sessions of laser therapy were required to control the bleeding with a median of 2737 J (range 1117–6160 J) per session. A median of 16 units (range 4–44) had been transfused prior to laser therapy and a median of four additional units (range 0–113) were transfused until bleeding was controlled. All patients were followed for at least 70 days after the last laser therapy session, with no further episodes of bleeding. Complications were mild and included abdominal pain and asymptomatic ulceration; however, one patient required gastrectomy due to gastric necrosis following transarterial embolizations. In summary, severe bleeding from GAVE is rare following hematopoietic cell transplant. Treatment with endoscopic therapy using the Nd:YAG laser is safe and effective.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaur S, Cooper G, Fakult S, Lazarus HM . Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci 1996; 413: 598–603.
Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F et al. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome. Am J Gastroenterol 2001; 962: 385–393.
Tobin RW, Hackman RC, Kimmey MB, Durtschi MB, Hayashi A, Malik R et al. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc 1996; 443: 223–229.
Ohashi K, Sanaka M, Tu Y, Egawa N, Ohashi K, Funata N et al. Clinical features and treatment of hematopoietic stem cell transplantation-associated gastric antral vascular ectasia. Bone Marrow Transplant 2003; 32: 417–421.
Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R . The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 1992; 15: 256–263.
Borsch G . Diffuse gastric antral vascular ectasia: the ‘watermelon stomach’ revisited. Am J Gastroenterol 1987; 82: 1333–1334.
Lee FI, Costello F, Flanagan N, Vasudev KS . Diffuse antral vascular ectasia. Gastrointest Endosc 1984; 30: 87–90.
Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962–968.
Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA et al. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplant 1996; 17: 943–950.
Tzung SP, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB . Lymphocytic gastritis resembling graft-vs-host disease following autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 1998; 4: 43–48.
Marmaduke DP, Greenson JK, Cunningham I, Herderick EE, Cornhill JF . Gastric vascular ectasia in patients undergoing bone marrow transplantation. Am J Clin Pathol 1994; 102: 194–198.
Hackman RC, Wolford JL, Gleaves CA, Myerson D, Beauchamp MD, Meyers JD et al. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. Transplantation 1994; 57: 231–237.
Pavey DA, Craig PI . Endoscopic therapy for upper-GI vascular ectasias. Gastrointest Endosc 2004; 59: 233–238.
Mathou NG, Lovat LB, Thorpe SM, Bown SG . Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach. Lasers Med Sci 2004; 18: 213–218.
Ng I, Lai KC, Ng M . Clinical and histological features of gastric antral vascular ectasia: successful treatment with endoscopic laser therapy. J Gastroenterol Hepatol 1996; 11: 270–274.
Sargeant IR, Loizou LA, Rampton D, Tulloch M, Brown SG . Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut 1993; 34: 470–475.
Liberski SM, McGarrity TJ, Hartle RJ, Varano V, Reynolds D . The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc 1994; 40: 584–587.
Jensen DM, Chaves DM, Grund KE . Endoscopic diagnosis and treatment of watermelon stomach. Endoscopy 2004; 36: 640–647.
Acknowledgements
Our research was supported by the following Grants from the National Institutes of Health, National Cancer Institute: CA 18029 and CA 15704.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Selinger, R., McDonald, G., Hockenbery, D. et al. Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Bone Marrow Transplant 37, 191–197 (2006). https://doi.org/10.1038/sj.bmt.1705212
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705212
Keywords
This article is cited by
-
Post-transplant gastric antral vascular ectasia after intra-venous busulfan regimen
International Journal of Hematology (2013)
-
Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease
International Journal of Hematology (2013)
-
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension
Current Treatment Options in Gastroenterology (2007)